Staff Reports
The more studies that come out about the COVID vaccine, the more I regret getting it. I already had the virus before I got the vaccine, and I was still able to get vaccinated and boost my immunity. I was surprised that I didn’t experience a cardiac event, as the death rates of young people in America have reportedly gone up.
RedState talked about Moderna's failure to provide adequate information about the safety and efficacy of its vaccine. According to an FDA panel member, they were not informed about the reinfection rate. The news outlet CNN also reported on this issue.
"""An FDA panel member said that he was angry that they weren't informed about the data that was relevant to the decision to use the vaccine. Paul Offit, who is a member of the panel that advises the agency, explained that the decisions that the public makes regarding vaccines should be based on all the available information."
During a meeting of an advisory group that the FDA held in June and another one that the CDC held in September, the experts were provided with updated information about the new COVID vaccine. According to a review of the meetings' slides and videos, the experts were able to see that the new vaccine works better than the one that was already on the market.
The data that the experts were presented with came from blood work that was done on study participants. They were able to measure the effectiveness of the different vaccines against the Omicron strain that causes COVID-19.
However, the data that they were not presented with related to actual infections. This included data on the individuals who caught the virus and those who didn't."""
"""Another observation that can be made is that Moderna's failure to provide the data related to the reinfection rate was not an oversight. The company might have known that the new vaccine would almost double the effectiveness of the current one, or they might have intentionally not informed the FDA advisory committee about this.
The company might have done this because it was cheaper to manufacture the new vaccine than it was to manufacture the old one."""
Despite the fact that pharmaceutical companies are protected from various types of lawsuits, they failed to provide the data related to the reinfection rate to the FDA. This was because they didn't want to risk losing money on the product. They also didn't want to face the potential backlash that would result from the data. I'm not surprised that the company failed to disclose this information before the political class, such as Fauci and the Democrats, threatened our employment.
Unfortunately, I'm not surprised that the company failed to disclose all of the data related to the revaccination rate before the political class, such as Fauci and the Democrats, threatened our employment.
The preceding is a summary of an article that originally appeared on Town Hall.
